Published in Br J Cancer Suppl on January 01, 1984
Radiosensitization in prostate cancer: mechanisms and targets. BMC Urol (2013) 0.81
(ADP-ribose)n participates in DNA excision repair. Nature (1980) 3.76
Poly(ADP-ribose) synthesis in vitro programmed by damaged DNA. A comparison of DNA molecules containing different types of strand breaks. J Biol Chem (1980) 2.60
Poly(ADP-ribose) and ADP-ribosylation of proteins. Rev Physiol Biochem Pharmacol (1976) 2.08
Regulation of DNA ligase activity by poly(ADP-ribose). Nature (1982) 1.91
ADP-ribosylation of nuclear proteins. Biochem Soc Trans (1980) 1.50
Inhibitors of poly(adenosine diphosphate ribose) polymerase induce sister chromatid exchanges. Biochem Biophys Res Commun (1980) 1.39
Unusual levels of (ADP-ribose)n and DNA synthesis in ataxia telangiectasia cells following gamma-ray irradiation. Nature (1980) 1.18
The enhancement of cytotoxicity of N-methyl-N-nitrosourea and of gamma-radiation by inhibitors of poly(ADP-ribose) polymerase. Eur J Biochem (1980) 1.17
Nuclear protein modification and chromatin substructure. 3. Relationship between poly(adenosine diphosphate) ribosylation and different functional forms of chromatin. Biochemistry (1979) 1.16
Role of poly(adenosine diphosphate ribose) in deoxyribonucleic acid repair in human fibroblasts. Biochemistry (1982) 1.14
Nuclear protein modification and chromatin substructure. 2. Internucleosomal localization of poly(adenosine diphosphate-ribose) polymerase. Biochemistry (1978) 1.07
The effect of inhibition of (ADP-ribose)n biosynthesis on DNA repair assayed by the nucleoid technique. Eur J Biochem (1981) 1.05
Evidence for adenosine diphosphate ribosylation of Ca2+, Mg2+-dependent endonuclease. Proc Natl Acad Sci U S A (1975) 1.04
Inhibitors of poly-(adenosine diphosphoribose) synthesis slow the resealing rate of x-ray-induced DNA strand breaks. Biochem Biophys Res Commun (1982) 1.04
Abnormal regulation of DNA replication and increased lethality in ataxia telangiectasia cells exposed to carcinogenic agents. Cancer Res (1982) 1.01
Defective poly(adenosine diphosphoribose) synthesis in xeroderma pigmentosum. Biochemistry (1980) 1.01
Nucleosome periodicity in HeLa cell chromatin as probed by micrococcal nuclease. Proc Natl Acad Sci U S A (1979) 0.92
ADP-ribosyltransferase activity in cultured hepatocytes. Interactions with DNA repair. J Biol Chem (1982) 0.91
Inhibition of (ADP-ribose)n biosynthesis retards DNA repair but does not inhibit DNA repair synthesis. Biochem Biophys Res Commun (1981) 0.91
Inhibition of deoxyribonuclease in an extract of rat liver nuclei by poly(ADP-ribose). Biochem Biophys Res Commun (1974) 0.87
Formation and resealing of intercalator-induced DNA strand breaks in permeabilized L1210 cells without the stimulated synthesis of poly(ADP-ribose). J Biol Chem (1982) 0.85
Contribution of incorporated 5-bromodeoxyuridine in DNA to the frequencies of sister-chromatid exchanges induced by inhibitors of poly-(ADP-ribose)-polymerase. Mutat Res (1981) 0.85
Ataxia-telangiectasia cells are not uniformly deficient in poly(ADP-ribose) synthesis following X-irradiation. Mutat Res (1983) 0.83
Nicotinamide stimulates repair of DNA damage in human lymphocytes. Biochem Biophys Res Commun (1980) 0.83
The effect of nicotinamide on unscheduled DNA synthesis in cultured hepatocytes. Biochem Biophys Res Commun (1980) 0.81
High incidence of sister chromatid exchanges and chromatid interchanges in the conditions of lowered activity of poly(ADP-ribose)polymerase. Biochem Biophys Res Commun (1981) 0.81
3-Aminobenzamide stimulates unscheduled DNA synthesis and rejoining of strand breaks in human lymphocytes. Biochem Biophys Res Commun (1981) 0.81
Inhibitors of poly(ADP-ribose) polymerase enhance unscheduled DNA synthesis in human peripheral lymphocytes. Biochem Biophys Res Commun (1981) 0.79
3-Aminobenzamide, an inhibitor of poly ADP-ribose polymerase, decreases the frequency of alkaline labile lesions and increases growth in human fibroblasts exposed to 3-methyl 4-nitroquinoline 1-oxide. Carcinogenesis (1982) 0.77
Vitamin C exhibits pro-oxidant properties. Nature (1998) 3.22
Renal impairment associated with non-steroidal anti-inflammatory drugs. Ann Rheum Dis (1987) 2.48
Hypoxic-reperfusion injury in the inflamed human joint. Lancet (1989) 2.11
P53 overexpression in head and neck carcinoma and radiotherapy results. Int J Radiat Oncol Biol Phys (1996) 2.06
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta (2002) 1.98
Quality assessment of genetic markers used for therapy stratification. J Clin Oncol (2003) 1.92
Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res (1997) 1.91
Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol (1981) 1.86
Mechanism of exacerbation of rheumatoid synovitis by total-dose iron-dextran infusion: in-vivo demonstration of iron-promoted oxidant stress. Lancet (1987) 1.69
Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. Nat Med (1996) 1.68
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line. Cancer Res (2001) 1.52
Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation. J Clin Invest (1985) 1.51
Raised cerebrospinal-fluid copper concentration in Parkinson's disease. Lancet (1987) 1.48
p53 and p53-regulated genes in bladder cancer. Br J Urol (1998) 1.46
Is chronic synovitis an example of reperfusion injury? Ann Rheum Dis (1986) 1.45
Clinical and molecular stratification of disease risk in medulloblastoma. Br J Cancer (2001) 1.43
Effect of intravenous iron dextran on rheumatoid synovitis. Ann Rheum Dis (1985) 1.41
C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value. J Urol (1996) 1.30
Cerebral and ocular toxicity induced by desferrioxamine. Q J Med (1985) 1.21
Statistical problems with 'optimal' thresholds in studies of new prognostic factors in urology. BJU Int (2000) 1.21
Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. Hepatology (1992) 1.18
Free radicals and antioxidant systems in health and disease. Br J Hosp Med (1990) 1.14
The impact of p53 status on cellular sensitivity to antifolate drugs. Clin Cancer Res (2001) 1.11
Fluorescent lipid-peroxidation products in synovial fluid. Clin Sci (Lond) (1979) 1.11
Urinary 8-oxo-2'-deoxyguanosine--source, significance and supplements. Free Radic Res (2000) 1.11
The behaviour of caeruloplasmin in stored human extracellular fluids in relation to ferroxidase II activity, lipid peroxidation and phenanthroline-detectable copper. Biochem J (1985) 1.11
Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma. Genes Chromosomes Cancer (2001) 1.10
p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells. Am J Pathol (2001) 1.10
Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group. Med Pediatr Oncol (2001) 1.08
Free radicals in biological systems--a review orientated to inflammatory processes. Br Med Bull (1987) 1.07
Free radical oxidation (peroxidation)products in plasma in normal and abnormal pregnancy. Ann Clin Biochem (1981) 1.07
Increased diene conjugates in diabetic subjects with microangiopathy. Diabet Med (1987) 1.04
MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63. Oncogene (2011) 1.02
The effects of vitamin C supplementation on protein oxidation in healthy volunteers. Biochem Biophys Res Commun (2000) 1.02
Molecular and cellular effects of ultraviolet light-induced genotoxicity. Crit Rev Clin Lab Sci (1998) 1.02
The human red blood cell glyoxalase system in diabetes mellitus. Diabetes Res Clin Pract (1989) 1.01
Histological profile of tumours from MYCN transgenic mice. J Clin Pathol (2008) 1.01
The role of the tumour suppressor p33 ING1b in human neoplasia. J Clin Pathol (2003) 1.01
Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation. Diabetologia (1991) 1.00
Expression of the ErbB-neuregulin signaling network during human cerebellar development: implications for the biology of medulloblastoma. Cancer Res (1998) 0.99
Non-caeruloplasmin-bound copper ('phenanthroline copper') is not detectable in fresh serum or synovial fluid from patients with rheumatoid arthritis. Biochem J (1987) 0.98
Fluorescence changes in human gamma-globulin induced by free-radical activity. Biochim Biophys Acta (1983) 0.98
Rapid lupus autoantigen relocalization and reactive oxygen species accumulation following ultraviolet irradiation of human keratinocytes. Rheumatology (Oxford) (2000) 0.98
Oxidative damage to DNA in patients with cystic fibrosis. Free Radic Biol Med (1995) 0.97
Ocular toxicity of desferrioxamine--an example of copper promoted auto-oxidative damage? Br J Ophthalmol (1989) 0.96
Induction and excretion of ultraviolet-induced 8-oxo-2'-deoxyguanosine and thymine dimers in vivo: implications for PUVA. J Invest Dermatol (2001) 0.96
Gefitinib ('Iressa', ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2. Br J Cancer (2004) 0.96
Downregulation of nuclear expression of the p33(ING1b) inhibitor of growth protein in invasive carcinoma of the breast. J Clin Pathol (2003) 0.96
The expression of functional MSH receptors on cultured human melanocytes. Arch Dermatol Res (1992) 0.96
Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Br J Cancer (2001) 0.94
Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours. Br J Cancer (1998) 0.93
Human lymphoblastoid cells with acquired resistance to C2-desamino-C2-methyl-N10-propargyl-5,8-dideazafolic acid: a novel folate-based thymidylate synthase inhibitor. Cancer Res (1992) 0.93
Reactive oxygen species selectively deplete normal T lymphocytes via a hydroxyl radical dependent mechanism. Scand J Immunol (1987) 0.93
Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma. United Kingdom Children's Cancer Study Group. Br J Cancer (2000) 0.92
Chain breaking antioxidant status in rheumatoid arthritis: clinical and laboratory correlates. Ann Rheum Dis (1991) 0.92
Low plasma ascorbate levels in patients with type 2 diabetes mellitus consuming adequate dietary vitamin C. Diabet Med (1994) 0.92
Novel repair action of vitamin C upon in vivo oxidative DNA damage. FEBS Lett (1998) 0.92
Endothelial cell cytotoxicity in inflammatory vascular diseases--the possible role of oxidised lipoproteins. Ann Rheum Dis (1985) 0.92
Reactive oxygen species modify human DNA, eliciting a more discriminating antigen for the diagnosis of systemic lupus erythematosus. Clin Exp Immunol (1990) 0.91
Ascorbic acid in the 21st century - more than a simple antioxidant. Environ Toxicol Pharmacol (2001) 0.91
Loss of nuclear expression of the p33(ING1b) inhibitor of growth protein in childhood acute lymphoblastic leukaemia. J Clin Pathol (2002) 0.91
Vitamin C metabolites and microangiopathy in diabetes mellitus. Diabetes Res (1987) 0.91
Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells. Br J Cancer (1991) 0.91
Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder. Clin Cancer Res (2001) 0.90
Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines. Lancet (1987) 0.90
The effects of oxygen free radicals on the carbohydrate moiety of IgG. FEBS Lett (1989) 0.90
Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis. Br J Cancer (1998) 0.90
Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines. Clin Cancer Res (1999) 0.89
Matrix metalloproteinases (MMPs) in bladder cancer: the induction of MMP9 by epidermal growth factor and its detection in urine. BJU Int (2003) 0.89
Frequency of H-ras mutations in human bladder cancer detected by direct sequencing. Br J Urol (1994) 0.89
Nuclear to cytoplasmic compartment shift of the p33ING1b tumour suppressor protein is associated with malignancy in melanocytic lesions. Histopathology (2002) 0.88
Reactive oxygen species induce antigenic changes in DNA. FEBS Lett (1989) 0.88
The neuroblastoma amplified gene, NAG: genomic structure and characterisation of the 7.3 kb transcript predominantly expressed in neuroblastoma. Gene (2003) 0.88
Effect of membrane fatty acid changes on the radiation sensitivity of human lymphoid cells. Int J Radiat Biol Relat Stud Phys Chem Med (1983) 0.88
In vitro screening of iron chelators using models of free radical damage. Free Radic Res Commun (1986) 0.88
erbB receptor expression patterns in human bladder cancer. Urology (2005) 0.88
A possible role for ferritin during inflammation. Free Radic Res Commun (1985) 0.87
Induction of metalloproteinase (MMP1) expression by epidermal growth factor (EGF) receptor stimulation and serum deprivation in human breast tumour cells. Eur J Cancer (1996) 0.87
Analysis of candidate gene co-amplification with MYCN in neuroblastoma. Eur J Cancer (1997) 0.87
Reactive oxygen species damage to DNA and its role in systemic lupus erythematosus. Mol Aspects Med (1991) 0.86
The predictive value of p53 and p33(ING1b) in patients with Dukes'C colorectal cancer. Colorectal Dis (2007) 0.86
Increased mdr1 gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay. Br J Cancer (1994) 0.86
The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy. Br J Cancer (2010) 0.86
Molecular characterisation of two cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694. Br J Cancer (1995) 0.86
Cultured human melanocytes respond to MSH peptides and ACTH. Pigment Cell Res (1994) 0.86
Immunogenicity of DNA damaged by reactive oxygen species--implications for anti-DNA antibodies in lupus. Free Radic Biol Med (1997) 0.86
Accumulation of wild-type p53 in meningiomas. Neuropathol Appl Neurobiol (1995) 0.85
Structural damage to lymphocyte nuclei by H2O2 or gamma irradiation is dependent on the mechanism of OH. radical production. Br J Cancer (1988) 0.85
Lipid peroxidation and Parkinson's disease. Lancet (1986) 0.85
Discrepancies in the measurement of UVC-induced 8-oxo-2'-deoxyguanosine: implications for the analysis of oxidative DNA damage. Biochem Biophys Res Commun (1999) 0.85
Aberrant processing of oxidative DNA damage in systemic lupus erythematosus. Biochem Biophys Res Commun (2000) 0.85
A novel HPLC procedure for the analysis of 8-oxoguanine in DNA. Free Radic Biol Med (1996) 0.85
Immunogenic and antigenic epitopes of immunoglobulin--XX. Denaturation of human IgG3 by free radicals. Mol Immunol (1987) 0.84
Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines. Genes Chromosomes Cancer (1998) 0.84
Oxidative damage to lipids within the inflamed human joint provides evidence of radical-mediated hypoxic-reperfusion injury. Am J Clin Nutr (1991) 0.84
Role of dietary antioxidants in the prevention of in vivo oxidative DNA damage. Nutr Res Rev (2002) 0.84
The extent of bonding of newly synthesized DNA to parent template in unirradiated cells as a prediction of radiation sensitivity. Int J Radiat Biol Relat Stud Phys Chem Med (1982) 0.84
Mitotic percentage index: a new prognostic factor for childhood medulloblastoma. Eur J Cancer (1997) 0.84
Effects of oxidative stress on some physiochemical properties of caeruloplasmin. Biochem J (1989) 0.83